By vgreene, 28 October, 2021 KEY FINDINGS no preventative effect from HCQ against SARS CoV 2 in pts w rheumatological conditions
By vgreene, 28 October, 2021 Long term Hydroxychloroquine Use in Patients With Rheumatic Conditions and Development of SARS CoV 2 Infection A Retrospective Cohort Study
By vgreene, 28 October, 2021 KEY FINDINGS no benefit of HCQ used as prophylaxis w in 4 days postexposure
By vgreene, 28 October, 2021 A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid 19
By vgreene, 28 October, 2021 KEY FINDINGS no clinical effect of HCQ post exposure prophylaxis to prevent SARS CoV 2 infection
By vgreene, 28 October, 2021 Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection A Randomized Trial
By vgreene, 28 October, 2021 KEY FINDINGS HCQ pre exposure prophylaxis given 1 2x wk did not reduce COVID 19 among healthcare workers
